STOCK TITAN

[Form 4] Eli Lilly & Co. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Edgardo Hernandez, EVP & President, Manufacturing Operations at Eli Lilly & Co. (LLY), reported changes in ownership on a Form 4. On 09/05/2025 he disposed of 17 shares of Eli Lilly common stock in a transaction coded G at a price of $0. After the reported disposition he directly beneficially owned 39,731.435 shares and indirectly held 872.3 shares through a 401(k). No derivative securities were reported. The form was signed on behalf of Mr. Hernandez on 09/08/2025.

Edgardo Hernandez, EVP e Presidente delle Operazioni di Produzione presso Eli Lilly & Co. (LLY), ha segnalato variazioni nella sua partecipazione tramite un modulo Form 4. In data 09/05/2025 ha ceduto 17 azioni ordinarie di Eli Lilly con codice di transazione G a un prezzo di $0. Dopo tale cessione risultava titolare diretto di 39.731,435 azioni e deteneva indirettamente 872,3 azioni tramite un piano 401(k). Non sono stati segnalati strumenti derivati. Il modulo è stato firmato per conto del Sig. Hernandez il 09/08/2025.

Edgardo Hernandez, EVP y Presidente de Operaciones de Fabricación en Eli Lilly & Co. (LLY), notificó cambios en su participación mediante un Formulario 4. El 09/05/2025 dispuso de 17 acciones ordinarias de Eli Lilly en una operación codificada como G a un precio de $0. Tras la disposición, poseía directamente 39.731,435 acciones y de forma indirecta 872,3 acciones a través de un 401(k). No se informaron valores derivados. El formulario fue firmado en nombre del Sr. Hernandez el 09/08/2025.

에드가르도 에르난데스님은 Eli Lilly & Co. (LLY)에서 제조 운영 담당 EVP 겸 사장으로서 Form 4를 통해 보유 변동을 보고했습니다. 2025-09-05에 코드 G로 표기된 거래에서 Eli Lilly 보통주 17주를 주당 $0에 처분했습니다. 해당 처분 후 그는 직접적으로 39,731.435주를 보유하고 있으며, 401(k)를 통해 간접적으로 872.3주를 보유하고 있습니다. 파생상품은 보고되지 않았습니다. 해당 서류는 2025-09-08에 에르난데스 씨를 대신해 서명되었습니다.

Edgardo Hernandez, EVP et Président des Opérations de Fabrication chez Eli Lilly & Co. (LLY), a déclaré des changements de détention sur un formulaire Form 4. Le 09/05/2025, il a cédé 17 actions ordinaires d'Eli Lilly lors d'une opération codée G au prix de $0. Après cette cession, il possédait directement 39 731,435 actions et détenait indirectement 872,3 actions via un plan 401(k). Aucun instrument dérivé n'a été signalé. Le formulaire a été signé au nom de M. Hernandez le 09/08/2025.

Edgardo Hernandez, EVP und Präsident der Fertigungsbetriebe bei Eli Lilly & Co. (LLY), meldete Eigentumsänderungen in einem Form 4. Am 09/05/2025 veräußerte er 17 Stammaktien von Eli Lilly in einer Transaktion mit dem Code G zu einem Preis von $0. Nach dieser Veräußerung hielt er direkt 39.731,435 Aktien und indirekt 872,3 Aktien über einen 401(k). Es wurden keine Derivate gemeldet. Das Formular wurde am 09/08/2025 im Namen von Herrn Hernandez unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Section 16 reporting of an insider disposition with direct and indirect holdings disclosed.

This Form 4 shows a single non-derivative disposition by an executive officer. The entry reports a transaction dated 09/05/2025 coded "G" for 17 shares at a reported price of $0, followed by disclosure of 39,731.435 shares directly owned and 872.3 shares held indirectly in a 401(k). There are no derivative positions reported. The filing appears administrative and complies with Section 16 reporting by identifying the reporting person, relationship to the issuer, transaction details, and signature authorization dated 09/08/2025.

TL;DR: Disclosure is concise and procedural; no material corporate governance changes are indicated.

The Form 4 provides required transparency about an insider transaction by an officer of LLY. It lists direct and indirect beneficial ownership and shows no new option grants or derivative activity. The presence of an authorized representative signature is noted. Based solely on the form's contents, this filing is a routine ownership update rather than a governance event.

Edgardo Hernandez, EVP e Presidente delle Operazioni di Produzione presso Eli Lilly & Co. (LLY), ha segnalato variazioni nella sua partecipazione tramite un modulo Form 4. In data 09/05/2025 ha ceduto 17 azioni ordinarie di Eli Lilly con codice di transazione G a un prezzo di $0. Dopo tale cessione risultava titolare diretto di 39.731,435 azioni e deteneva indirettamente 872,3 azioni tramite un piano 401(k). Non sono stati segnalati strumenti derivati. Il modulo è stato firmato per conto del Sig. Hernandez il 09/08/2025.

Edgardo Hernandez, EVP y Presidente de Operaciones de Fabricación en Eli Lilly & Co. (LLY), notificó cambios en su participación mediante un Formulario 4. El 09/05/2025 dispuso de 17 acciones ordinarias de Eli Lilly en una operación codificada como G a un precio de $0. Tras la disposición, poseía directamente 39.731,435 acciones y de forma indirecta 872,3 acciones a través de un 401(k). No se informaron valores derivados. El formulario fue firmado en nombre del Sr. Hernandez el 09/08/2025.

에드가르도 에르난데스님은 Eli Lilly & Co. (LLY)에서 제조 운영 담당 EVP 겸 사장으로서 Form 4를 통해 보유 변동을 보고했습니다. 2025-09-05에 코드 G로 표기된 거래에서 Eli Lilly 보통주 17주를 주당 $0에 처분했습니다. 해당 처분 후 그는 직접적으로 39,731.435주를 보유하고 있으며, 401(k)를 통해 간접적으로 872.3주를 보유하고 있습니다. 파생상품은 보고되지 않았습니다. 해당 서류는 2025-09-08에 에르난데스 씨를 대신해 서명되었습니다.

Edgardo Hernandez, EVP et Président des Opérations de Fabrication chez Eli Lilly & Co. (LLY), a déclaré des changements de détention sur un formulaire Form 4. Le 09/05/2025, il a cédé 17 actions ordinaires d'Eli Lilly lors d'une opération codée G au prix de $0. Après cette cession, il possédait directement 39 731,435 actions et détenait indirectement 872,3 actions via un plan 401(k). Aucun instrument dérivé n'a été signalé. Le formulaire a été signé au nom de M. Hernandez le 09/08/2025.

Edgardo Hernandez, EVP und Präsident der Fertigungsbetriebe bei Eli Lilly & Co. (LLY), meldete Eigentumsänderungen in einem Form 4. Am 09/05/2025 veräußerte er 17 Stammaktien von Eli Lilly in einer Transaktion mit dem Code G zu einem Preis von $0. Nach dieser Veräußerung hielt er direkt 39.731,435 Aktien und indirekt 872,3 Aktien über einen 401(k). Es wurden keine Derivate gemeldet. Das Formular wurde am 09/08/2025 im Namen von Herrn Hernandez unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hernandez Edgardo

(Last) (First) (Middle)
LILLY CORPORATE CENTER

(Street)
INDIANAPOLIS IN 46285

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Pres., Mfg. Operations
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 G 17 D $0 39,731.435 D
Common Stock 872.3 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Jonathan Groff for Edgardo Hernandez, pursuant to authorization on file 09/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider reported the transaction for LLY?

The reporting person is Edgardo Hernandez, EVP & President, Manufacturing Operations.

When was the transaction reported on the Form 4 for LLY?

The transaction date is 09/05/2025, and the form is signed on behalf of the reporting person on 09/08/2025.

What securities and amounts were reported in the LLY Form 4?

The filing reports a disposition of 17 shares of Eli Lilly common stock, leaving 39,731.435 shares directly owned and 872.3 shares indirectly held via a 401(k).

Were any derivative securities reported in this LLY Form 4?

No. Table II for derivative securities contains no reported transactions.

What transaction code was used in the Form 4 filing for LLY and what price was reported?

The transaction is coded G with a reported price of $0.
Lilly Eli & Co

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data

651.91B
944.35M
0.16%
83.87%
0.8%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS